Baker Brothers Advisors - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$7,599,134
-7.6%
2,499,7150.0%0.04%
-8.3%
Q2 2023$8,224,062
+3.5%
2,499,7150.0%0.05%
+11.6%
Q1 2023$7,949,094
-54.0%
2,499,7150.0%0.04%
-58.7%
Q4 2022$17,298,028
+9.3%
2,499,7150.0%0.10%0.0%
Q3 2022$15,823,000
+52.9%
2,499,7150.0%0.10%
+76.3%
Q2 2022$10,349,000
-14.6%
2,499,7150.0%0.06%
-15.7%
Q1 2022$12,124,000
-51.4%
2,499,7150.0%0.07%
-42.1%
Q4 2021$24,972,000
-47.7%
2,499,7150.0%0.12%
-42.4%
Q3 2021$47,770,000
+558.1%
2,499,715
+1001.3%
0.21%
+556.2%
Q2 2021$7,259,000
+6.1%
226,9880.0%0.03%
+6.7%
Q1 2021$6,844,000
-30.3%
226,9880.0%0.03%
-18.9%
Q4 2020$9,822,000
-27.8%
226,988
-9.9%
0.04%
-31.5%
Q3 2020$13,595,000
-16.0%
252,000
-4.9%
0.05%
-23.9%
Q2 2020$16,176,000
+780.1%
265,000
+562.5%
0.07%
+545.5%
Q1 2020$1,838,000
-47.6%
40,0000.0%0.01%
-42.1%
Q4 2019$3,510,000
-4.4%
40,0000.0%0.02%
-24.0%
Q3 2019$3,673,000
-27.8%
40,0000.0%0.02%
-28.6%
Q2 2019$5,088,000
-19.1%
40,0000.0%0.04%
-12.5%
Q1 2019$6,293,000
+58.6%
40,0000.0%0.04%
+25.0%
Q4 2018$3,968,000
-54.3%
40,000
-32.7%
0.03%
-43.9%
Q3 2018$8,678,000
-72.4%
59,441
-70.3%
0.06%
-75.8%
Q2 2018$31,390,000
-8.1%
200,0000.0%0.24%
-18.3%
Q1 2018$34,150,000
-4.1%
200,0000.0%0.29%
-6.5%
Q4 2017$35,620,000
+7.4%
200,000
-17.2%
0.31%
+14.9%
Q3 2017$33,162,000
+4.7%
241,441
-19.9%
0.27%
-2.9%
Q2 2017$31,666,000
-0.9%
301,441
-14.2%
0.28%
+6.1%
Q1 2017$31,946,000
+47.3%
351,4410.0%0.26%
+22.5%
Q4 2016$21,684,000
+8.8%
351,441
+19.6%
0.21%
+17.7%
Q3 2016$19,923,000
+56.6%
293,9430.0%0.18%
+36.1%
Q2 2016$12,725,000
-15.2%
293,943
-16.7%
0.13%
-15.8%
Q1 2016$15,000,000
+65.5%
352,943
+150.1%
0.16%
+110.7%
Q4 2015$9,062,000
-24.9%
141,1050.0%0.08%
-33.0%
Q3 2015$12,072,000
-52.6%
141,105
-6.6%
0.11%
-49.8%
Q2 2015$25,442,000
+43.7%
151,105
+3.1%
0.22%
+51.7%
Q1 2015$17,703,000
+28.7%
146,581
-2.3%
0.15%
+5.0%
Q4 2014$13,758,000
+155.6%
150,0000.0%0.14%
+105.9%
Q3 2014$5,382,000
-29.6%
150,000
-24.3%
0.07%
-27.7%
Q2 2014$7,647,000
+69.6%
198,2600.0%0.09%
+64.9%
Q1 2014$4,508,000
+87.8%
198,260
+73.2%
0.06%
+67.6%
Q4 2013$2,401,000
-20.2%
114,461
+2.6%
0.03%
-20.9%
Q3 2013$3,007,000111,5210.04%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 145,000$25,825,0006.29%
Monashee Investment Management LLC 37,500$6,679,0002.83%
Eventide Asset Management 277,603$49,441,0002.58%
Redmile Group, LLC 259,800$46,270,0002.01%
MayTech Global Investments, LLC 16,477$2,935,0001.93%
First Light Asset Management, LLC 37,838$6,739,0001.85%
Atika Capital Management LLC 26,500$4,720,0001.82%
Taylor Wealth Management Partners 22,993$4,095,0001.74%
ARK Investment Management 121,462$21,632,0001.72%
Cormorant Asset Management, LP 80,000$14,248,0001.49%
View complete list of BLUEBIRD BIO INC shareholders